We are live on ! Find out more
COGT icon

Cogent Biosciences
COGT

135 hedge funds and large institutions have $859M invested in Cogent Biosciences in 2022 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 53 increasing their positions, 37 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,929% more call options, than puts

Call options by funds: $704K | Put options by funds: $14K

43% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 37

5% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 21

1% more funds holding

Funds holding: 134 → 135 (+1)

8.57% less ownership

Funds ownership: 115.69% → 107.12% (-8.6%)

14% less funds holding in top 10

Funds holding in top 10: 7 → 6 (-1)

24% less capital invested

Capital invested by funds: $1.13B → $859M (-$270M)

Holders
135
Holders Change
+1
Holders Change %
+0.75%
% of All Funds
2.17%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.1%
New
22
Increased
53
Reduced
37
Closed
21
Calls
$704K
Puts
$14K
Net Calls
+$690K
Net Calls Change
-$418K

Top Buyers

1
RCM
RA Capital Management
Massachusetts
+$24.6M
2
Marshall Wace
Marshall Wace
United Kingdom
+$18.3M
3
LGM
Logos Global Management
California
+$13.6M
4
State Street
State Street
Massachusetts
+$10.6M
5
Citadel Advisors
Citadel Advisors
Florida
+$6.47M

Top Sellers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$22M
2
APM
Avidity Partners Management
Texas
-$20.3M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$15.7M
4
BI
BVF Inc
California
-$13.6M
5
CAM
Cormorant Asset Management
Massachusetts
-$6.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
76
Deutsche Bank
Germany
$408K +$105K +8,456 +32%
DekaBank Deutsche Girozentrale
77
DekaBank Deutsche Girozentrale
Germany
$402K +$434K +35,000 New
Tudor Investment Corp
78
Tudor Investment Corp
Connecticut
$400K +$429K +34,606 New
MIM
79
MetLife Investment Management
New Jersey
$393K – – –
State of Wisconsin Investment Board
80
State of Wisconsin Investment Board
Wisconsin
$380K +$408K +32,902 New
Susquehanna International Group
81
Susquehanna International Group
Pennsylvania
$359K -$551K -44,458 -59%
AIG
82
American International Group
New York
$350K -$1.36K -110 -0.4%
WC
83
Wexford Capital
Florida
$347K – – –
Mirae Asset Global Investments
84
Mirae Asset Global Investments
South Korea
$344K +$84.3K +6,801 +30%
CS
85
Credit Suisse
Switzerland
$300K +$318K +25,626 +7,079%
Walleye Trading
86
Walleye Trading
New York
$299K +$320K +25,854 New
Manulife (Manufacturers Life Insurance)
87
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$285K +$83.2K +6,716 +37%
VOYA Investment Management
88
VOYA Investment Management
Georgia
$283K – – –
EGM
89
Engineers Gate Manager
New York
$281K +$301K +24,303 New
AQR Capital Management
90
AQR Capital Management
Connecticut
$272K +$292K +23,549 New
SG Americas Securities
91
SG Americas Securities
New York
$262K -$22K -1,774 -7%
IAM
92
Innovis Asset Management
Illinois
$261K +$280K +22,556 New
UBS AM
93
UBS AM
Illinois
$257K +$275K +22,200 New
BHCM
94
Boulder Hill Capital Management
New York
$231K +$248K +20,000 New
Invesco
95
Invesco
Georgia
$204K -$5.45M -439,868 -96%
V
96
Veritable
Delaware
$199K – – –
EFM
97
E Fund Management
China
$196K +$32K +2,585 +18%
State Board of Administration of Florida Retirement System
98
State Board of Administration of Florida Retirement System
Florida
$173K +$7.43K +600 +4%
LPL Financial
99
LPL Financial
California
$171K -$18.6K -1,500 -9%
Principal Financial Group
100
Principal Financial Group
Iowa
$169K +$181K +14,580 New
2 3
4
5 6

COGT Hedge Fund Activity: Q4 2022 in Review

135 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Cogent Biosciences (COGT) for Q4 2022, worth a combined $859M — down 24% from $1.13B a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new COGT positions and 21 closed out — a net gain of 1 holder — while 53 added to existing stakes and 37 trimmed.

The largest buyer was RA Capital Management, adding an estimated $24.6M. The largest seller was Janus Henderson Group, cutting an estimated $22M.

  • 135 institutional investors held Cogent Biosciences (COGT) as of Q4 2022, up from 134 in Q3 2022.
  • Funds reported $859M of Cogent Biosciences stock for Q4 2022, down 24% quarter-over-quarter.
  • 22 funds opened new Cogent Biosciences positions in Q4 2022 and 21 closed out, a net change of +1 holder.
  • The largest Cogent Biosciences buyer in Q4 2022 was RA Capital Management, an estimated $24.6M added.
  • The largest Cogent Biosciences seller in Q4 2022 was Janus Henderson Group, an estimated $22M sold.

Based on aggregated 13F filings for Q4 2022.